Next Generation Sequencing: What's Real? What's Hype? And What Can You Use Now?
Next-Generation Sequencing. Deep Sequencing. Third Generation Sequencing. From academia to industry and from popular press to Wall Street, the amount of attention and coverage devoted to new sequencing technologies is unprecedented. But in a world of real research, clinical and diagnostic needs -- and real, pressing deadlines -- how can your organization actually take advantage of sequencing today?
Join us as our panelists discuss ways that sequencing is making an impact in the lab and in the clinic today -- and how your planning for the coming months and years must factor in the impact of these technologies.
Vern Norviel, Partner, Wilson, Sonsini, Goodrich & Rosati, Palo Alto
Martin Nealy, Head of Medical Sequencing Technologies, Life Technologies
Eric Schoenmakers, Ph.D., Research Fellow Precision Medicine, Oncology Research Unit, Pfizer
Tina Hambuch, Scientific Liaison and CGMBS Education Director, Illumina
David S. Johnson, PhD, CEO and Co-Founder, Gigagen
Networking and Breakfast: 7:30 - 8:00am, Program 8-9am
Click here for directions and parking information.
|When||Wednesday, October 26, 2011
7:30 a.m. - 9:00 a.m.
Add to Calendar
|RSVP||Tuesday, October 25, 2011 2:00 p.m.|
12400 High Bluff Drive
San Diego, California 92130
Get Driving Directions